You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DYN Sale Disclosure
Rhodes Jason P · SEC Form 4 · Filed Aug 17, 2026
Sale
Calculated transaction value
$2.47M
Rhodes Jason P Director
DYN
Transaction date
Aug 13, 2026
Public filing date
Aug 17, 2026
Filing lag
Filed 4 days later
DYN daily price context
Close on/before transaction
$25.96
Aug 13, 2026
First close after public filing
$26
Aug 18, 2026
30-day return after filing
-33.44%
Through Sep 16, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 94,415 shares @ $26.2
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001577014-26-000016
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$65.18M
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Dyne Therapeutics, Inc. DYN | Sale | Aug 14, 2026 | $33.99M |
| Dyne Therapeutics, Inc. DYN | Sale | Aug 14, 2026 | $11.96M |
| Dyne Therapeutics, Inc. DYN | Sale | Aug 14, 2026 | $8.06M |
| Dyne Therapeutics, Inc. DYN | Sale | Aug 13, 2026 | $7.03M |
| Dyne Therapeutics, Inc. DYN Current | Sale | Aug 13, 2026 | $2.47M |
| Dyne Therapeutics, Inc. DYN | Sale | Aug 13, 2026 | $1.67M |